Fengyuan Che

机构：Linyi People's Hospital

发表论文 11 篇 · 总被引 1092 次 · h-index 7

代表论文

• Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial (2023 · The Lancet · 被引 313)
• Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy (2024 · New England Journal of Medicine · 被引 226)
• Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke (2024 · JAMA · 被引 101)
• Reteplase versus Alteplase for Acute Ischemic Stroke (2024 · New England Journal of Medicine · 被引 98)
• Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial (2024 · The Lancet · 被引 45)
• Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter Trial (2023 · Cerebrovascular Diseases · 被引 9)